Apyx Medical (NASDAQ: APYX) is one of 119 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare Apyx Medical to related businesses based on the strength of its analyst recommendations, dividends, earnings, institutional ownership, risk, valuation and profitability.
Valuation & Earnings
This table compares Apyx Medical and its peers top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Apyx Medical||$38.88 million||-$5.06 million||-50.00|
|Apyx Medical Competitors||$1.52 billion||$155.88 million||-192.67|
Volatility and Risk
Apyx Medical has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, Apyx Medical’s peers have a beta of 1.11, suggesting that their average stock price is 11% more volatile than the S&P 500.
Institutional & Insider Ownership
39.1% of Apyx Medical shares are owned by institutional investors. Comparatively, 50.8% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 5.7% of Apyx Medical shares are owned by company insiders. Comparatively, 15.8% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This table compares Apyx Medical and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Apyx Medical Competitors||-29.27%||-40.61%||-15.82%|
This is a summary of current ratings and target prices for Apyx Medical and its peers, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Apyx Medical Competitors||739||2663||4834||240||2.54|
Apyx Medical currently has a consensus price target of $10.00, indicating a potential upside of 17.65%. As a group, “Surgical & medical instruments” companies have a potential upside of 376.21%. Given Apyx Medical’s peers higher probable upside, analysts clearly believe Apyx Medical has less favorable growth aspects than its peers.
Apyx Medical peers beat Apyx Medical on 7 of the 13 factors compared.
Apyx Medical Company Profile
Apyx Medical Corporation provides products in the cosmetic and surgical markets worldwide. The company markets Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. Its Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.